Nuvigil FDA Approval History
FDA Approved: Yes (First approved June 15, 2007)
Brand name: Nuvigil
Generic name: armodafinil
Dosage form: Tablets
Company: Cephalon, Inc.
Treatment for: Narcolepsy
Nuvigil (armodafinil) is a non-amphetamine wake-promoting agent for the treatment of excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome (OSAHS), narcolepsy, and shift work sleep disorder (SWSD).
Development timeline for Nuvigil
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.